Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
- Revenue in JPY (TTM)868.87bn
- Net income in JPY115.74bn
- Incorporated1919
- Employees31.65k
- LocationOlympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
- Phone+81 333402111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fisher & Paykel Healthcare Corp Ltd | 160.80bn | 42.68bn | 980.35bn | 6.90k | 23.07 | 7.51 | 19.88 | 6.10 | 0.8978 | 0.8978 | 3.38 | 2.76 | 1.07 | 2.70 | 8.26 | 284,326.50 | 28.31 | 23.13 | 34.39 | 28.55 | 63.81 | 65.33 | 26.54 | 22.33 | 1.83 | -- | 0.0671 | 53.79 | 55.99 | 19.31 | 82.46 | 29.59 | 22.94 | 17.87 |
| Cochlear Limited | 141.90bn | 23.39bn | 1.28tn | 4.00k | 54.90 | 8.24 | 42.21 | 9.05 | 3.95 | 3.95 | 23.95 | 26.30 | 0.6573 | 1.84 | 5.62 | 393,775.00 | 10.83 | 10.59 | 12.83 | 14.49 | 74.58 | 73.92 | 16.48 | 12.25 | 2.55 | -- | 0.1333 | 92.66 | 13.40 | 5.78 | 237.01 | 11.56 | 14.09 | 2.09 |
| Terumo Corp | 703.30bn | 88.81bn | 3.13tn | 26.48k | 35.13 | 3.08 | 17.85 | 4.45 | 117.40 | 117.40 | 929.71 | 1,338.46 | 0.4979 | 1.79 | 5.31 | -- | 6.29 | 6.98 | 7.29 | 8.29 | 52.52 | 53.80 | 12.63 | 13.45 | 2.03 | 79.48 | 0.1825 | 25.22 | 14.57 | 6.47 | 14.94 | 10.06 | 13.93 | 10.12 |
| Olympus Corp | 868.87bn | 115.74bn | 3.49tn | 31.65k | 29.82 | 6.71 | 19.35 | 4.02 | 90.18 | 90.18 | 676.99 | 400.75 | 0.6838 | 1.82 | 5.17 | -- | 9.13 | 5.83 | 12.64 | 8.36 | 65.80 | 64.40 | 13.35 | 7.81 | 1.40 | 63.26 | 0.4302 | 21.46 | 18.93 | 3.25 | 76.44 | 22.02 | 0.5139 | 14.87 |
| FUJIFILM Holdings Corp | 2.53tn | 211.18bn | 3.54tn | 73.28k | 13.08 | 1.10 | 10.53 | 1.40 | 526.11 | 526.11 | 6,292.46 | 6,244.29 | 0.6731 | 3.24 | 4.56 | -- | 5.42 | 4.68 | 7.05 | 6.15 | 40.91 | 40.54 | 8.05 | 6.90 | 1.25 | -- | 0.1505 | 23.49 | 15.20 | 1.70 | 16.54 | 9.94 | 11.34 | 9.46 |
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Mar 2022 | 76.03m | 5.85% |
| Baillie Gifford & Co.as of 30 Jun 2021 | 65.60m | 5.05% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2022 | 60.46m | 4.65% |
| Nikko Asset Management Co., Ltd.as of 15 Jun 2021 | 42.08m | 3.24% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Jun 2021 | 37.31m | 2.87% |
| Daiwa Asset Management Co. Ltd.as of 28 Apr 2022 | 35.66m | 2.74% |
| The Vanguard Group, Inc.as of 05 May 2022 | 27.03m | 2.08% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 28 Mar 2022 | 19.91m | 1.53% |
| BlackRock Fund Advisorsas of 04 May 2022 | 18.17m | 1.40% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2022 | 17.16m | 1.32% |
